Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage

BACKGROUND: Pulmonary fibrosis (PF) is a growing clinical problem with limited therapeutic options. Human umbilical cord mesenchymal stromal cell (hucMSC) therapy is being investigated in clinical trials for the treatment of PF patients. However, little is known about the underlying molecular and ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zan, Gao, Junxiao, Wu, Jie, Zeng, Guifang, Liao, Yan, Song, Zhenkun, Liang, Xiao, Hu, Junyuan, Hu, Yong, Liu, Muyun, Li, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278716/
https://www.ncbi.nlm.nih.gov/pubmed/34256845
http://dx.doi.org/10.1186/s13287-021-02469-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278716/
https://www.ncbi.nlm.nih.gov/pubmed/34256845
http://dx.doi.org/10.1186/s13287-021-02469-5

Ejemplares similares